BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Heart
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tecovirimat
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A Case of Neonatal Monkeypox Treated With Oral Tecovirimat.
Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, N…
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate…
Development and Validation of a Method of Liquid Chromatography Coupled with Tandem Mass Spectrometr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tecovirimat for Treatment of Monkeypox Virus
Tecovirimat in Non-hospitalized Patients With Monkeypox
Study of Tecovirimat for Human Monkeypox Virus
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound …
Tecovirimat Intravenous Treatment for Orthopox Virus Exposure
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ